Arrhythmic Manifestations and Management in Hospitalized COVID-19 Patients
Completed
Conditions studied: Coronavirus Infections
In brief
Although arrhythmias appear to be common in COVID-19 patients, arrhythmia mechanisms and characteristics, predisposing factors, incidence of sudden cardiac death and predictors, therapeutic strategies employed as well as long term outcomes are not well understood. Hence, we seek to develop a multicenter registry aimed to characterize arrhythmic manifestations, employed treatment strategies and long-term outcomes among hospitalized COVID-19 patients in the US.
Key facts
- Study ID
- NCT04465552
- Run by
- Kansas City Heart Rhythm Research Foundation
- People needed
- 666
- Starts
- 2020-07-10
- Expected to finish
- 2021-01-24
- Last updated by the study team
- 2021-09-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients > 18 years of age
- Hospital admission with COVID-19
You may not qualify if…
- ● Age < 18 years
Where it is running
- Kansas City Heart Rhythm Institute — Overland Park, Kansas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.